![Michael Vasconcelles](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 35 109 $ au 30/06/2026
Michael J.
Vasconcelles currently serves as Independent Non-Executive Director at Molecular Partners AG since 2020, Director at Molecular Partners, Inc., Independent Director at Kura Oncology, Inc. since 2024, Senior Advisor at Frazier Management LLC since 2019, Head-Research & Development at Day One Biopharmaceuticals, Inc. starting 2025, and is a Member of both the American Society of Clinical Oncology, Inc. and the American Society of Hematology.
Former roles include Director at American Cancer Society, New England Division, Inc., Independent Director at Magenta Therapeutics, Inc., Director at Personalized Medicine Coalition, Chief Medical Officer at Cogent Biosciences, Inc. from 2015 to 2019, Executive VP-Research & Medical Affairs at ImmunoGen, Inc. from 2023 to 2024, Faculty Member at Harvard Medical School from 1996 to 2021, Chief Medical Officer at Flatiron Health, Inc. from 2019 to 2022, Senior VP & Head-Oncology Therapy Area Unit at Takeda Pharmaceuticals International, Inc. from 2012 to 2015, Global Therapeutic Area Head-Transplant & Oncology at Sanofi, Group VP & Head-Global Therapeutic Area at Genzyme Corp.
from 2000 to 2011, and Head-Personalized Medicine & Companion Diagnostics at Sanofi Oncology from 2011 to 2012.
Education includes undergraduate studies at Northwestern University and a doctorate from Feinberg School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MOLECULAR PARTNERS AG 0,02 % | 31/12/2025 | 9 048 ( 0,02 % ) | 35 109 $ | 30/06/2026 |
KURA ONCOLOGY, INC. -.--% | 04/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULAR PARTNERS AG | Directeur/Membre du Conseil | 29/04/2020 |
| KURA ONCOLOGY, INC. | Directeur/Membre du Conseil | 17/09/2024 |
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 10/06/2025 |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Consultant / Advisor | 01/01/2019 |
American Society of Hematology
 American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOGEN, INC. | Directeur Technique/Scientifique/R&D | 01/02/2024 |
Flatiron Health, Inc.
 Flatiron Health, Inc. Packaged SoftwareTechnology Services Develops health care technology | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| ░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 20 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm targets companies operating in the fields of medical products & distribution, pharmaceuticals and healthcare service sectors. It provides financing for buyout and growth stage capital requirements. | Finance |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services Operates as a hematology membership organisation | Commercial Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
American Cancer Society, New England Division, Inc. | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Personalized Medicine Coalition
 Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services Engages in promoting the understanding and adoption of personalized medicine concepts, services and products | Commercial Services |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
Flatiron Health, Inc.
Flatiron Health, Inc. Packaged SoftwareTechnology Services Develops health care technology | Technology Services |
Feinberg School of Medicine
 Feinberg School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines | Health Technology |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Sanofi Oncology
 Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Provides Salesforce and strategic consulting services | Commercial Services |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
